SREBF2 and neoplasm: In situations in which lipids and/or oxygen is limited, such as in the glioblastoma microenvironment, the master transcription factor SREBP2 and its downstream targets, including mevalonate-pathway enzymes are significantly upregulated in tumor (Lewis et al., 2015).